Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
This grant funds translational research efforts aimed at advancing gene-based therapies for ultra-rare neurological and neuromuscular disorders.
About this program
The grant supports innovative research projects that focus on the development and application of gene-based therapies specifically targeting ultra-rare neurological and neuromuscular disorders. It aims to facilitate the translation of scientific discoveries into clinical applications that can significantly improve patient outcomes. Researchers and institutions engaged in this field are encouraged to apply, particularly those with a strong background in gene therapy and related disciplines. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that can demonstrate the capability to conduct clinical trials or related research. The grant is designed to foster collaboration among researchers, clinicians, and industry partners to accelerate the development of effective therapies for these challenging conditions. Projects should outline clear methodologies and expected outcomes to ensure the successful advancement of gene-based treatments.
Eligibility
Academic institutions, nonprofit organizations, and research entities with capabilities in clinical trials.